111 related articles for article (PubMed ID: 24502136)
21. P450(BM3) (CYP102A1): connecting the dots.
Whitehouse CJ; Bell SG; Wong LL
Chem Soc Rev; 2012 Feb; 41(3):1218-60. PubMed ID: 22008827
[TBL] [Abstract][Full Text] [Related]
22. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis.
Huang WC; Cullis PM; Raven EL; Roberts GC
Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430
[TBL] [Abstract][Full Text] [Related]
23. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
Chen HC; Swenson RP
Biochemistry; 2008 Dec; 47(52):13788-99. PubMed ID: 19055322
[TBL] [Abstract][Full Text] [Related]
24. Rational design of a minimal and highly enriched CYP102A1 mutant library with improved regio-, stereo- and chemoselectivity.
Seifert A; Vomund S; Grohmann K; Kriening S; Urlacher VB; Laschat S; Pleiss J
Chembiochem; 2009 Mar; 10(5):853-61. PubMed ID: 19222039
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic probes of flavocytochrome P-450 BM3.
Noble MA; Turner KL; Chapman SK; Munro AW
Biochem Soc Trans; 1998 Aug; 26(3):S213. PubMed ID: 9765932
[No Abstract] [Full Text] [Related]
26. Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium.
Budde M; Morr M; Schmid RD; Urlacher VB
Chembiochem; 2006 May; 7(5):789-94. PubMed ID: 16566047
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for the properties of two single-site proline mutants of CYP102A1 (P450BM3).
Whitehouse CJ; Yang W; Yorke JA; Rowlatt BC; Strong AJ; Blanford CF; Bell SG; Bartlam M; Wong LL; Rao Z
Chembiochem; 2010 Dec; 11(18):2549-56. PubMed ID: 21110374
[TBL] [Abstract][Full Text] [Related]
28. Fatty acid hydroxylase of the fungus Fusarium oxysporum is possibly a fused protein of cytochrome P-450 and its reductase.
Nakayama N; Shoun H
Biochem Biophys Res Commun; 1994 Jul; 202(1):586-90. PubMed ID: 8037765
[TBL] [Abstract][Full Text] [Related]
29. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.
Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH
Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587
[TBL] [Abstract][Full Text] [Related]
30. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites.
Damsten MC; van Vugt-Lussenburg BM; Zeldenthuis T; de Vlieger JS; Commandeur JN; Vermeulen NP
Chem Biol Interact; 2008 Jan; 171(1):96-107. PubMed ID: 17996858
[TBL] [Abstract][Full Text] [Related]
31. Protein and electrode engineering for the covalent immobilization of P450 BMP on gold.
Ferrero VE; Andolfi L; Di Nardo G; Sadeghi SJ; Fantuzzi A; Cannistraro S; Gilardi G
Anal Chem; 2008 Nov; 80(22):8438-46. PubMed ID: 18947200
[TBL] [Abstract][Full Text] [Related]
32. Structure, dynamics, and function of the monooxygenase P450 BM-3: insights from computer simulations studies.
Roccatano D
J Phys Condens Matter; 2015 Jul; 27(27):273102. PubMed ID: 26061496
[TBL] [Abstract][Full Text] [Related]
33. Hole Hopping through Tryptophan in Cytochrome P450.
Ener ME; Gray HB; Winkler JR
Biochemistry; 2017 Jul; 56(28):3531-3538. PubMed ID: 28689401
[TBL] [Abstract][Full Text] [Related]
34. Cleaning AFM colloidal probes by mechanically scrubbing with supersharp "brushes".
Gan Y; Franks GV
Ultramicroscopy; 2009 Jul; 109(8):1061-5. PubMed ID: 19361930
[TBL] [Abstract][Full Text] [Related]
35. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
[TBL] [Abstract][Full Text] [Related]
36. Biocatalytic route to chiral acyloins: P450-catalyzed regio- and enantioselective α-hydroxylation of ketones.
Agudo R; Roiban GD; Lonsdale R; Ilie A; Reetz MT
J Org Chem; 2015 Jan; 80(2):950-6. PubMed ID: 25495724
[TBL] [Abstract][Full Text] [Related]
37. P450 BM3: the very model of a modern flavocytochrome.
Munro AW; Leys DG; McLean KJ; Marshall KR; Ost TW; Daff S; Miles CS; Chapman SK; Lysek DA; Moser CC; Page CC; Dutton PL
Trends Biochem Sci; 2002 May; 27(5):250-7. PubMed ID: 12076537
[TBL] [Abstract][Full Text] [Related]
38. Hydroxylation of anilides by engineered cytochrome P450
O'Hanlon JA; Ren X; Morris M; Wong LL; Robertson J
Org Biomol Chem; 2017 Oct; 15(41):8780-8787. PubMed ID: 29019509
[TBL] [Abstract][Full Text] [Related]
39. Regioselective hydroxylation of omeprazole enantiomers by bacterial CYP102A1 mutants.
Ryu SH; Park BY; Kim SY; Park SH; Jung HJ; Park M; Park KD; Ahn T; Kang HS; Yun CH
Drug Metab Dispos; 2014 Sep; 42(9):1493-7. PubMed ID: 25008345
[TBL] [Abstract][Full Text] [Related]
40. CH-activating oxidative hydroxylation of 1-tetralones and related compounds with high regio- and stereoselectivity.
Roiban GD; Agudo R; Ilie A; Lonsdale R; Reetz MT
Chem Commun (Camb); 2014 Nov; 50(92):14310-3. PubMed ID: 25168091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
